Receptor for advanced glycation end products (RAGE): Novel biomarker and therapeutic target for atrial fibrillation

International Journal of Cardiology

Volumn 168, Issue 5, 2013, Pages 4802-4804

  Zhang, Qitong ^a   Li, Guangping ^a   Liu, Tong ^a  

^a SECOND HOSPITAL OF TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Atrial fibrillation; Atrial remodeling; Biomarker; Inflammation; RAGE

Indexed keywords

2 ISOPROPYLIDENEHYDRAZONO 4 OXO 5 THIAZOLIDINYLACETANILIDE; ACETYLCYSTEINE; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ALAGEBRIUM; COLLAGEN; HEMOGLOBIN A1C; REACTIVE OXYGEN METABOLITE;

CATHETER ABLATION; DRUG EFFICACY; DRUG MECHANISM; HEART ATRIUM FIBRILLATION; HEART ATRIUM FIBROSIS; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HUMAN; INFLAMMATION; LETTER; MOLECULAR INTERACTION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RNA SPLICING; SIGNAL TRANSDUCTION;

ATRIAL FIBRILLATION; ATRIAL REMODELING; BIOMARKER; INFLAMMATION; RAGE;

HUMANS; INFLAMMATION; RECEPTORS, IMMUNOLOGIC; VASCULAR DISEASES;

EID: 84886388040     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.07.038     Document Type: Article

References (28)

1. P. Korantzopoulos, T.M. Kolettis, and E. Kountouris Inflammation and anti-inflammatory interventions in atrial fibrillation Int J Cardiol 104 2005 361 362
2. P. Korantzopoulos, T.M. Kolettis, D. Galaris, and J.A. Goudevenos The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation Int J Cardiol 115 2007 135 143
3. K. Toutouzas, M. Drakopoulou, and P. Dilaveris Inflammation in lone atrial fibrillation: new insights by coronary sinus thermography Int J Cardiol 134 2009 345 350
4. N. Mahajan, and V. Dhawan Receptor for advanced glycation end products (RAGE) in vascular and inflammatory diseases Int J Cardiol 2013 10.1016/j.ijcard.2013.05.013
5. S. Yamagishi, H. Adachi, and K. Nakamura Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects Metabolism 55 2006 1227 1231
6. D. Zhao, Y. Wang, and Y. Xu Decreased serum endogenous secretory receptor for advanced glycation endproducts and increased cleaved receptor for advanced glycation endproducts levels in patients with atrial fibrillation Int J Cardiol 158 2012 471 472
7. H. Yonekura, Y. Yamamoto, and S. Sakurai Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury Biochem J 370 2003 1097 1109
8. G. Basta Receptor for advanced glycation endproducts and atherosclerosis: from basic mechanisms to clinical implications Atherosclerosis 196 2008 9 21
9. L. Lu, L.J. Pu, and Q. Zhang Increased glycated albumin and decreased esRAGE levels are related to angiographic severity and extent of coronary artery disease in patients with type 2 diabetes Atherosclerosis 206 2009 540 545
10. L.J. Wang, L. Lu, F.R. Zhang, Q.J. Chen, R. De Caterina, and W.F. Shen Increased serum high-mobility group box-1 and cleaved receptor for advanced glycation endproducts levels and decreased endogenous secretory receptor for advanced glycation endproducts levels in diabetic and non-diabetic patients with heart failure Eur J Heart Fail 13 2011 440 449
11. X.R. Hu, X.H. Wang, H.F. Liu, W.J. Zhou, and H. Jiang High mobility group box 1 protein: possible pathogenic link to atrial fibrillation Chin Med J (Engl) 125 2012 2346 2348
12. S.M. Twigg, A.H. Joly, and M.M. Chen Connective tissue growth factor/IGF-binding protein-related protein-2 is a mediator in the induction of fibronectin by advanced glycosylation end-products in human dermal fibroblasts Endocrinology 143 2002 1260 1269
13. S.M. Twigg, Z. Cao, and S.V. MCLennan Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine Endocrinology 143 2002 4907 4915
14. R. Candido, J.M. Forbes, and M.C. Thomas A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes Circ Res 92 2003 785 792
15. L. van Heerebeek, N. Hamdani, and M.L. Handoko Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension Circulation 117 2008 43 51
16. R. Mukherjee, A.R. Herron, and A.S. Lowry Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation Am J Cardiol 97 2006 532 537
17. Y. Nakano, S. Niida, and K. Dote Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation J Am Coll Cardiol 43 2004 818 825
18. M.A. Hofmann, S. Drury, and C. Fu RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides Cell 97 1999 889 901
19. R.K. Wong, A.I. Pettit, P.A. Quinn, S.C. Jennings, J.E. Davies, and L.L. Ng Advanced glycation end products stimulate an enhanced neutrophil respiratory burst mediated through the activation of cytosolic phospholipase A2 and generation of arachidonic acid Circulation 108 2003 1858 1864
20. S. Raposeiras-Roubin, B.K. Rodino-Janeiro, and L. Grigorian-Shamagian Evidence for a role of advanced glycation end products in atrial fibrillation Int J Cardiol 157 2012 397 402
21. S. Raposeiras-Roubin, C. Barreiro-Parda, and F. Roubin-Camina Advanced glycation end products: a mysterious shadow beyond the relationship between HbA1c and atrial fibrillation Int J Cardiol 157 2012 441
22. Y. Iguchi, K. Kimura, and K. Shibazaki HbA1c and atrial fibrillation: a cross-sectional study in Japan Int J Cardiol 156 2012 156 159
23. X. Yan, Y. Shen, L. Lu, M. Sano, K. Fukuda, and W. Shen Decreased endogenous secretory RAGE and increased hsCRP levels in serum are associated with atrial fibrillation in patients undergoing coronary angiography Int J Cardiol 166 2013 242 245
24. T. Kato, T. Yamashita, and A. Sekiguchi AGEs-RAGE system mediates atrial structural remodeling in the diabetic rat J Cardiovasc Electrophysiol 19 2008 415 420
25. G.R. Norton, G. Candy, and A.J. Woodiwiss Aminoguanidine prevents the decreased myocardial compliance produced by streptozotocin-induced diabetes mellitus in rats Circulation 93 1996 1905 1912
26. S. Yamagishi, Y. Inagaki, and T. Okamoto Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells J Biol Chem 277 2002 20309 20315
27. W.J. Gu, Z.J. Wu, P.F. Wang, L.H. Aung, and R.X. Yin N-acetylcysteine supplementation for the prevention of atrial fibrillation after cardiac surgery: a meta-analysis of eight randomized controlled trials BMC Cardiovasc Disord 12 2012 10
28. T. Liu, and G. Li Antioxidant interventions as novel preventive strategies for postoperative atrial fibrillation Int J Cardiol 145 2010 140 142